Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good
news, but clinicians must also recognize that this brings new challenges to the medical …

Objectives: This study sought to evaluate the efficacy of enalapril and carvedilol to prevent
chemotherapy-induced left ventricular systolic dysfunction (LVSD) in patients with …

This User's Guide is intended to support the design, implementation, analysis, interpretation,
and quality evaluation of registries created to increase understanding of patient outcomes …

Background—An increase in troponin I soon after high-dose chemotherapy (HDC) is a
strong predictor of poor cardiological outcome in cancer patients. This finding has important …

Recent advances in radiotherapy have enabled the use of different types of particles, such
as protons and heavy ions, as well as refinements to the treatment of tumours with standard …

Improvements in early detection, supportive care, and treatment have resulted in an
increasing number of cancer survivors, with a current 5-year relative survival rate for all …

The idea of recording information on all cancer cases in defined communities dates from the
first half of the twentieth century, and there has been a steady growth in the number of such …

Second and higher-order malignancies now comprise about 18% of all incident cancers in
the USA, superseding first primary cancers of the breast, lung, and prostate. The occurrence …

Cancer therapy through anticancer drugs and radiotherapy is associated with several side
effects as well as tumor resistance to therapy. The genotoxic effects of chemotherapy and …